Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs
- 1 September 2014
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 109, 54-63
Abstract
No abstract availableKeywords
Funding Information
- National Basic Research Program of China (2009CB522504)
- Important National Science & Technology Specific Projects (2009ZX09301-014)
- Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-10-03)
This publication has 54 references indexed in Scilit:
- Phenothiazines Inhibit Hepatitis C Virus Entry, Likely by Increasing the Fluidity of Cholesterol-Rich MembranesAntimicrobial Agents and Chemotherapy, 2013
- Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling studyThe Lancet Infectious Diseases, 2012
- High-Throughput Screening for Anti–Influenza A Virus Drugs and Study of the Mechanism of Procyanidin on Influenza A Virus–Induced AutophagySLAS Discovery, 2012
- Selective Serotonin Reuptake Inhibitor Suppression of HIV Infectivity and ReplicationPsychosomatic Medicine, 2010
- The Clinically Approved Proteasome Inhibitor PS-341 Efficiently Blocks Influenza A Virus and Vesicular Stomatitis Virus Propagation by Establishing an Antiviral StateJournal of Virology, 2010
- Effects of chlorophyllin on replication of poliovirus and bovine herpesvirusin vitroLetters in Applied Microbiology, 2009
- Increased Survival after Gemfibrozil Treatment of Severe Mouse InfluenzaAntimicrobial Agents and Chemotherapy, 2007
- Antiviral agents active against influenza A virusesNature Reviews Drug Discovery, 2006
- Anthralin: Historical and current perspectivesJournal of the American Academy of Dermatology, 1983
- THE INACTIVATION OF INFLUENZA VIRUSES BY TANNIC ACID AND RELATED COMPOUNDSJournal of Bacteriology, 1953